ADC Therapeutics Income Statement (2019-2023) | ADCT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Revenue & cost
Revenue 30.54B-77.11B0.00B25.95B-0.00B0.00B0.00B0.01B0.02B0.05B0.02B0.08B0.07B0.02B0.02B0.01B
Cost of Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B
Gross Profit 0.00B0.01B0.02B0.05B0.02B0.08B0.07B0.02B0.00B0.00B
Operating items
Amortization - Intangibles -2.0019.000.00B25.0038.0033.0033.0026.0031.0031.0030.0052.0051.0052.00
Research & Development -0.00B-0.00B-0.00B0.04B-0.03B-0.03B-0.04B-0.04B-0.04B-0.00B-0.05B-0.05B-0.04B-0.00B-0.04B0.03B0.03B
Selling, General & Administrative -0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.02B-0.02B-0.02B-0.00B-0.02B-0.02B-0.02B-0.00B-0.02B0.01B0.01B
Restructuring Costs -0.00B0.01B0.01B0.00B0.00B
Other Operating Expenses -0.07B-0.00B-0.01B-0.01B-0.02B-0.02B-0.01B-0.03B-0.02B-0.02B-0.00B-0.02B0.02B0.01B
Operating Expenses -0.00B-0.00B-0.00B-0.04B-0.04B-0.05B-0.07B-0.07B-0.07B-0.00B-0.09B-0.09B-0.08B-0.00B-0.07B0.06B0.05B
Operating Income -0.02B-0.03B-0.04B-0.04B-0.04B-0.05B-0.07B-0.07B-0.06B-0.06B-0.04B-0.07B-0.00B-0.01B-0.05B-0.04B-0.04B
EBIT -0.02B-0.03B-0.04B-0.04B-0.04B-0.05B-0.07B-0.07B-0.06B-0.06B-0.04B-0.07B-0.00B-0.01B-0.05B-0.04B-0.04B
Non-operating items
Interest & Investment Income 647.00729.00218.000.00B0.00B0.00B-15.000.00B0.00B20.000.02B0.00B0.00B0.00B-0.00B0.00B0.00B
Other Non Operating Income -0.08B0.03B0.02B0.00B-0.01B-0.00B-0.00B0.01B-0.04B0.01B0.00B0.00B
Non Operating Income 532.000.00B562.00-0.00B0.00B0.02B-0.00B-0.01B0.00B0.01B0.01B-0.04B-0.00B-0.00B-0.01B-0.01B
Net income details
EBT -0.00B-0.00B-0.00B-0.04B-0.13B-0.02B-0.05B-0.07B-0.07B-0.00B-0.02B-0.07B-0.05B-0.00B-0.06B-0.05B-0.05B
Tax Provisions -105.00-268.00-115.00-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B
Profit After Tax -0.00B-0.00B-0.00B0.04B-0.13B-0.02B-0.00B-0.07B-0.07B-0.00B-0.00B-0.06B-0.05B-0.00B-0.00B-0.05B-0.05B
Equity Income -0.00B-0.00B
Income from Continuing Operations -0.00B-0.00B-0.00B-0.04B-0.13B-0.02B-0.05B-0.07B-0.07B-0.00B-0.02B-0.07B-0.05B-0.00B-0.06B-0.05B-0.05B
Consolidated Net Income -0.00B-0.00B-0.00B-0.04B-0.13B-0.02B-0.05B-0.07B-0.07B-0.00B-0.02B-0.07B-0.05B-0.00B-0.06B-0.05B-0.05B
Income towards Parent Company -0.00B-0.00B-0.00B0.04B0.13B0.02B0.05B0.07B0.07B-0.00B0.02B0.06B0.05B-0.00B-0.06B-0.05B-0.05B
Net Income towards Common Stockholders -0.00B-0.00B-0.00B0.04B0.13B0.02B0.05B0.07B0.07B-0.00B0.02B0.06B0.05B-0.00B-0.06B-0.05B-0.05B
Additional items
EPS (Basic) 0.000.651.890.290.670.950.930.000.220.840.660.00-0.74-0.73-0.57
EPS (Weighted Average and Diluted) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B-0.73-0.57
Shares Outstanding (Weighted Average) 0.07B0.07B0.07B0.07B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B
Shares Outstanding (Diluted Average) 0.00B670.000.00B0.00B220.000.00B0.00B740.000.08B0.08B
EBITDA -0.02B-0.03B-0.04B-0.04B-0.04B-0.05B-0.07B-0.07B-0.06B-0.06B-0.04B-0.07B-0.00B-0.01B-0.05B-0.04B-0.04B
Interest Expenses 0.01B0.01B
Tax Rate 0.40%0.86%0.33%0.23%0.08%0.21%0.33%0.20%19.65%8.54%0.22%